| Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers W Xu, M Xu, L Wang, W Zhou, R Xiang, Y Shi, Y Zhang, Y Piao Signal transduction and targeted therapy 4 (1), 55, 2019 | 121 | 2019 |
| CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism R Gao, D Li, J Xun, W Zhou, J Li, J Wang, C Liu, X Li, W Shen, H Qiao, ... Theranostics 8 (22), 6248, 2018 | 75 | 2018 |
| Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling Z Huang, W Zhou, Y Li, M Cao, T Wang, Y Ma, Q Guo, X Wang, C Zhang, ... Theranostics 8 (18), 4995, 2018 | 51 | 2018 |
| IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer W Gao, H Wen, L Liang, X Dong, R Du, W Zhou, X Zhang, C Zhang, ... Theranostics 11 (6), 2564, 2021 | 50 | 2021 |
| Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma S Wu, T Fukumoto, J Lin, T Nacarelli, Y Wang, D Ong, H Liu, ... Nature cancer 2 (2), 189-200, 2021 | 48 | 2021 |
| TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness R Du, W Shen, Y Liu, W Gao, W Zhou, J Li, S Zhao, C Chen, Y Chen, ... Signal transduction and targeted therapy 4 (1), 60, 2019 | 46 | 2019 |
| TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and-independent signaling pathways W Shen, R Du, J Li, X Luo, S Zhao, A Chang, W Zhou, R Gao, D Luo, ... Signal Transduction and Targeted Therapy 1 (1), 1-10, 2016 | 40 | 2016 |
| TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer W Shen, A Chang, J Wang, W Zhou, R Gao, J Li, Y Xu, X Luo, R Xiang, ... Oncogenesis 4 (10), e173-e173, 2015 | 34 | 2015 |
| Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype X Hao, B Zhao, W Zhou, H Liu, T Fukumoto, D Gabrilovich, R Zhang IScience 24 (1), 2021 | 33 | 2021 |
| The SETDB1–TRIM28 complex suppresses antitumor immunity J Lin, D Guo, H Liu, W Zhou, C Wang, I Müller, AV Kossenkov, R Drapkin, ... Cancer immunology research 9 (12), 1413-1424, 2021 | 31 | 2021 |
| Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway Y Xu, J Mou, Y Wang, W Zhou, Q Rao, H Xing, Z Tian, K Tang, M Wang, ... Leukemia 36 (2), 403-415, 2022 | 29 | 2022 |
| PFKFB4 promotes breast cancer metastasis via induction of hyaluronan production in a p38-dependent manner R Gao, Y Liu, D Li, J Xun, W Zhou, P Wang, C Liu, X Li, W Shen, W Su, ... Cellular Physiology and Biochemistry 50 (6), 2108-2123, 2018 | 27 | 2018 |
| Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer J Lin, H Liu, T Fukumoto, J Zundell, Q Yan, CHA Tang, S Wu, W Zhou, ... Nature communications 12 (1), 5321, 2021 | 26 | 2021 |
| Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis Z Huang, B Zhao, Z Qin, Y Li, T Wang, W Zhou, J Zheng, S Yang, Y Shi, ... European Journal of Medicinal Chemistry 181, 111541, 2019 | 24 | 2019 |
| Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway H Niu, W Zhou, Y Xu, Z Yin, W Shen, Z Ye, Y Liu, Y Chen, S Yang, ... Oncotarget 8 (44), 76266, 2017 | 23 | 2017 |
| Clinical significance and functional validation of PPA1 in various tumors D Luo, G Wang, W Shen, S Zhao, W Zhou, L Wan, L Yuan, S Yang, ... Cancer Medicine 5 (10), 2800-2812, 2016 | 22 | 2016 |
| Highly selective, potent, and oral mTOR inhibitor for treatment of cancer as autophagy inducer Q Guo, C Yu, C Zhang, Y Li, T Wang, Z Huang, X Wang, W Zhou, Y Li, ... Journal of medicinal chemistry 61 (3), 881-904, 2018 | 18 | 2018 |
| The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma S Zhao, S Fang, Y Liu, X Li, S Liao, J Chen, J Liu, L Zhao, H Li, W Zhou, ... Oncotarget 8 (21), 34374, 2017 | 18 | 2017 |
| Ifit1 protects against lipopolysaccharide and D-galactosamine–induced fatal hepatitis by inhibiting activation of the JNK pathway A Chang, Y Chen, W Shen, R Gao, W Zhou, S Yang, Y Liu, Y Luo, ... The Journal of infectious diseases 212 (9), 1509-1520, 2015 | 18 | 2015 |
| Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis W Zhou, H Liu, Z Yuan, J Zundell, M Towers, J Lin, S Lombardi, H Nie, ... Cancer cell 41 (4), 740-756. e10, 2023 | 15 | 2023 |
Heng LiuThe Wistar InstituteVerified email at wistar.org
